comparemela.com

Latest Breaking News On - Alex vukasin - Page 1 : comparemela.com

Challenges in China spell trouble for Illumina, 10x and others

China’s recovery from its zero-COVID policy has failed to gain the momentum expected, with many experts predicting a slow or even negative growth rate. A slower economy, combined with a push toward self-reliance, bodes poorly for diagnostics manufacturers in the U.S. who may find themselves not just shut out of the huge market but facing stiffer competition around the globe. Further, policies designed to build a domestic next-generation sequencing industry have created headwinds for San Diego-based Illumina Inc. and others, noted Kyle Mikson and Alex Vukasin of Canaccord Genuity in an in-depth report.

China
Canaccord-genuity
Kyle-mikson
Alex-vukasin
San-illumina-inc
San-diego-based-illumina
Next-generation-sequencing
Rings
Spatial-biology
Single-cell-analysis
Diagnostics

Biodesix, Inc. (NASDAQ:BDSX) Q1 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by and welcome to the Biodesix First Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode.

United-states
Andrew-brackmann
Alex-vukasin
William-blair
Canaccord-genuity
Chris-brinzey
Scott-hutton
Robin-harper-cowie
Oracle
Biodesix-inc
Exchange-commission-on
Nasdaq

Quantum-Si incorporated (NASDAQ:QSI) Q4 2022 Earnings Call Transcript

Operator: Ladies and gentlemen, thank you for standing by. Welcome to Quantum-Si Fourth Quarter Fiscal Year 2022 Earnings Call. At this time, all participants are in a listen-only mode.

Chicago
Illinois
United-states
Garnet-valley
Pennsylvania
Canaccord-genuity
Kyle-nixon
Claudia-drayton
Yuan-zhi
Jeff-hawkins
Merck-millipore
Juan-avendano

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.